DL-3-Methylaspartic acid

DL-3-Methylaspartic acid is an aspartic acid derivative bearing a side-chain methyl substituent at the 3-position relative to the α-carboxylate, yielding a stereochemically defined amino acid framework in which the α-amino and α-carboxyl groups coexist with an additional carboxylate functionality characteristic of aspartate chemistry. The DL designation indicates racemic material, providing both enantiomeric forms that can be leveraged for method development, racemate-to-enantiomer workflows, and comparative structure-property studies. The molecule's two carboxylic acid groups and the secondary amine enable controlled protection/deprotection strategies and predictable coupling behavior after conversion to activated derivatives. Functional group reactivity centers on amide/ester formation, salt formation, and side-chain methyl-driven steric and electronic effects that can influence peptide incorporation and downstream derivatization.

1. Peptide Synthesis

DL-3-Methylaspartic acid is applied in peptide building block preparation and coupling chemistry where the aspartate-like backbone supports conversion to protected amino acid derivatives for standard peptide coupling protocols. The presence of two carboxyl groups enables selective N-protection and controlled activation of the side-chain carboxyl for orthogonal peptide assembly and C-terminal or side-chain-specific functionalization. Racemic availability can be used for generating peptide libraries that probe stereochemical effects, while subsequent resolution or enantiomer-selective incorporation can be pursued when chiral outcomes are required. Downstream peptide analogs derived from this amino acid can serve as tools for mapping how 3-methyl substitution modulates backbone conformation, charge distribution, and proteolytic stability in peptide science.

2. Amino Acid Derivatization

DL-3-Methylaspartic acid is utilized as a chemical intermediate for amino acid derivatization routes that target carboxyl group functional transformation into esters, amides, or activated intermediates for further synthetic elaboration. The dual carboxylate functionality supports orthogonal protection strategies, such as selective esterification or temporary masking of one acid group while the other participates in coupling or derivatization. The side-chain methyl group can be exploited to generate sterically constrained analogs that may alter solubility, reactivity, or binding behavior in subsequent scaffolds. Resulting derivatives can be used for fine chemical synthesis, including preparation of constrained amino acid reagents, carboxyl-activated intermediates, and functionalized aspartate mimics used in synthetic methodology development.

3. Chiral Resolution Studies

DL-3-Methylaspartic acid is suitable for stereochemical method development, including racemate-to-enantiomer workflows and analytical comparisons of enantiomer-specific behavior. The molecule's chiral center(s) associated with the aspartate backbone and the 3-methyl substituent enable formation of diastereomeric salts or derivatives with chiral reagents, which can be monitored by chromatographic or spectroscopic methods. The racemic starting composition supports screening of resolving agents and evaluation of derivatization conditions to improve stereochemical control for downstream peptide incorporation. Enantiomer-enriched products derived from resolution can then feed into stereochemically defined amino acid chemistry, enabling more interpretable structure-property relationships in peptide science and chiral building block design.

4. Chemical Biology Probes

DL-3-Methylaspartic acid is applied in chemical biology research as a component of amino acid-based probes and biomolecule-modifying reagents where aspartate-like charge and side-chain substitution can influence molecular recognition. The two carboxyl groups allow conjugation handle creation after conversion to activated esters or amide-forming intermediates, supporting attachment to linkers, affinity tags, or reporter moieties. The 3-methyl substitution can be used to tune steric environment around the side-chain carboxyl, which may affect conjugate stability and interaction profiles in labeling experiments. Probe constructs prepared from this amino acid can serve as biochemical research intermediates for studying binding preferences, substrate recognition, or enzyme tolerance toward modified aspartate residues.

5. Pharmaceutical Intermediate Preparation

DL-3-Methylaspartic acid is employed in pharmaceutical intermediate preparation and process chemistry contexts where controlled functional group manipulation of an amino acid scaffold is required for downstream synthesis of peptidomimetic or polar building blocks. The amino and carboxyl functionalities support conversion into protected forms compatible with stepwise assembly, while the side-chain methyl group provides a defined steric element that can influence crystallinity, solubility, and solid-state behavior of intermediates. Orthogonal protection and activation of the carboxyl groups can be used to design manufacturing routes that minimize cross-reactivity during multistep synthesis. Prepared derivatives can function as chiral or achiral intermediates for medicinal chemistry programs focused on amino acid-like motifs and aspartate-mimicking pharmacophores, including candidates for structure-activity relationship studies.

6. Analytical Standards Development

DL-3-Methylaspartic acid is used for analytical research and method validation where a defined amino acid derivative supports calibration, identification, and stability assessment in chromatographic and spectrometric workflows. Dual carboxyl groups and the amino functionality enable robust derivatization and predictable ionization behavior, aiding quantitation in amino acid profiling and impurity monitoring. Racemic composition can be leveraged to generate reference patterns for enantiomeric separation method development and to support mass balance studies during synthetic transformations. Analytical standards and derivative forms prepared from this compound can support routine characterization of protected amino acid intermediates, peptide building blocks, and related aspartate analogs in chemical manufacturing and research laboratories.

1. The effect of sex on immune responses to a homocitrullinated peptide in the DR4-transgenic mouse model of Rheumatoid Arthritis

2. Sex differences in oxidative stress level and antioxidative enzymes expression and activity in obese pre-diabetic elderly rats treated with metformin or liraglutide

3. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment

4. Myotropic activity of allatostatins in tenebrionid beetles

5. Therapeutic potential of an intestinotrophic hormone, glucagon-like peptide 2, for treatment of type 2 short bowel syndrome rats with intestinal bacterial and fungal dysbiosis